scholarly journals Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis

Hematology ◽  
2021 ◽  
Vol 27 (1) ◽  
pp. 23-31
Author(s):  
Timothy Devos ◽  
Dominik Selleslag ◽  
Nikki Granacher ◽  
Violaine Havelange ◽  
Fleur Samantha Benghiat
Sign in / Sign up

Export Citation Format

Share Document